NovoCure (NVCR) EPS (Basic) Growth (3y) (2017 - 2026)
Powered by 
Analysis
NovoCure (NVCR) EPS (Basic) Growth (3y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.08 Bn | 178.48 Bn | 7.27 Bn | -12.28% |
| 2 | Intuitive Surgical | 124.33 Bn | 119.11 Bn | 1.96 Bn | 24.18% |
| 3 | Medtronic | 118.50 Bn | 109.68 Bn | 6.34 Bn | 24.57% |
| 4 | Stryker | 106.32 Bn | 102.85 Bn | 4.50 Bn | 19.63% |
| 5 | Boston Scientific | 66.81 Bn | 66.27 Bn | 3.85 Bn | 50.64% |
| 6 | Edwards Lifesciences | 49.73 Bn | 45.48 Bn | 1.35 Bn | -6.23% |
| 7 | Alcon | 34.03 Bn | 32.57 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.17 Bn | 30.23 Bn | 830.00 Mn | 29.56% |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn | 17.98% |
| 10 | NovoCure | 1.90 Bn | 1.46 Bn | 142.48 Mn | 37.02% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.02% |
| Mar 31, 2026 | -7.46% |
| Dec 31, 2025 | 14.88% |
| Sep 30, 2025 | -9.54% |
| Jun 30, 2025 | -16.17% |
| Mar 31, 2025 | -91.08% |
| Dec 31, 2024 | -33.70% |
| Sep 30, 2024 | -30.69% |
| Jun 30, 2024 | -29.87% |
| Mar 31, 2024 | -107.89% |
| Dec 31, 2023 | -122.96% |
| Sep 30, 2023 | -91.78% |
| Jun 30, 2023 | -226.72% |
| Mar 31, 2023 | -144.91% |
| Dec 31, 2022 | -116.41% |
| Sep 30, 2022 | -146.24% |
| Jun 30, 2022 | -159.18% |
| Mar 31, 2022 | 29.66% |
| Dec 31, 2021 | -14.54% |
| Sep 30, 2021 | -0.17% |